The Absence of Desmin Leads to Cardiomyocyte Hypertrophy and Cardiac Dilation with Compromised Systolic Function
- 1 November 1999
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 31 (11), 2063-2076
- https://doi.org/10.1006/jmcc.1999.1037
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A 5′ Dystrophin Duplication Mutation Causes Membrane Deficiency of -Dystroglycan in a Family with X-linked CardiomyopathyJournal of Molecular and Cellular Cardiology, 1997
- MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart FailureCell, 1997
- Desmin in Muscle Formation and Maintenance: Knockouts and Consequences.Cell Structure and Function, 1997
- Intermediate Filament-mediated Stretch-induced Changes in Chromatin: A Hypothesis for Growth Initiation in Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 1996
- Pressure- and Volume-Induced Left Ventricular Hypertrophies Are Associated With Distinct Myocyte Phenotypes and Differential Induction of Peptide Growth Factor mRNAsCirculation, 1995
- Desmin myopathy: a multisystem disorder involving skeletal, cardiac, and smooth muscleHuman Pathology, 1995
- Peak filling rate normalized to mitral stroke volume: A new Doppler echocardiographic filling index validated by radionuclide angiographic techniquesJournal of the American College of Cardiology, 1988
- Regional changes in myocyte size during the reversal of thyroid-inducedcardiac hypertrophyJournal of Molecular and Cellular Cardiology, 1988
- Characterization and regulation in the expression of a gene coding for the intermediate filament protein desmin.Proceedings of the National Academy of Sciences, 1984
- Tissue-specific expression of two mRNA species transcribed from a single vimentin geneCell, 1983